Imide derivatives for inhibiting the production of interleukin-1

Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514212, 514352, 514357, 514376, 514398, 514423, 514440, 514466, 514471, 514616, 546312, 546337, 548229, 5483185, 548540, 549 77, 549439, 549496, 564152, 564155, A61K 3116, A61K 31635, C07C23300, C07D20700, C07D21300, C07D26300

Patent

active

058471235

ABSTRACT:
Imide compounds having a propioloyl group or pharmaceutically acceptable salts thereof which exhibit potent activities to inhibit the production of Interleukin 1-.beta. and also the production of Tumor Necrosis Factor .alpha.. These imide compounds are useful as a prophylactic or therapeutic agent for inhibiting the production of Interleukin 1-.beta. and the production of Tumor Necrosis Factor .alpha., typically for such diseases as chronic rheumatism, sepsis, ulcerative colitis, Crohn's disease and many other related diseases in which Interleukin 1-.beta. and/or Tumor Necrosis Factor .alpha. would participate.

REFERENCES:
patent: 5137905 (1992-08-01), Moon et al.
patent: 5231179 (1993-07-01), Terashima et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imide derivatives for inhibiting the production of interleukin-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imide derivatives for inhibiting the production of interleukin-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imide derivatives for inhibiting the production of interleukin-1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-178646

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.